Fallon and Donovan of FHO Partners arranges 5,506 s/f lease relocation for Reflectance Medical

According to FHO Partners, a 5,506 s/f lease relocation for Reflectance Medical has been completed. The company will open its new office at 116 Flanders Rd. "We were pleased to assist Reflectance Medical in the company's site selection process and decision to relocate to 116 Flanders Rd.," said Joe Fallon, managing partner at FHO. "This amenity-rich and convenient location offers this young firm the ideal environment to mature and flourish as it continues to develop breakthrough medical technologies." Fallon and senior vice president Sue Donovan of FHO Partners represented Reflectance Medical. The landlord was Carruth Capital. Located 33 miles west of downtown, near Mass I- 495 and the Boston Worcester Turnpike, 116 Flanders Rd. is situated in the Metrowest Business Park, which contains a three-story, class-A office building against 65 acres of conservation land. The park's amenities include a conferencing facility, covered parking, day care, golf course, hotel and on-site dining. FHO Partners is a commercial real estate firm offering a full range of brokerage, consulting, strategic planning, research, lease administration, marketing, lease auditing, lease portfolio and transaction management services for corporate and institutional clients alike. The senior partners of the firm have worked together for over 20 years providing customized advisory consulting and brokerage services to an extensive range of corporate and institutional clients, both locally and on a national and international basis. Reflectance Medical Inc. is an early stage company developing new technology to revolutionize the care of critically ill patients by reducing medical costs and deaths associated with conditions which result in poor tissue perfusion and acidosis. The company's noninvasive CareGuide patient monitor continuously and quantitatively displays levels of microvascular oxygen, pH and hematocrit to provide treatment goals to assure rapid and successful reversal of microvascular abnormalities associated with internal bleeding, trauma, cardiac failure and sepsis.